RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies

CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers

(2009) Sarai Palanca Suela et al.   BREAST CANCER RESEARCH AND TREATMENT

Test of Hardy–Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions

(2009) Ke-Da Yu et al.   BREAST CANCER RESEARCH AND TREATMENT

Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer

(2009) Renata Krupa et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer

(2009) Ke-Da Yu et al.   FASEB JOURNAL

Common Single-Nucleotide Polymorphisms in DNA Double-Strand Break Repair Genes and Breast Cancer Risk

(2008) K. A. Pooley et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Polymorphisms in RAD51, XRCC2, and XRCC3 Are Not Related to Breast Cancer Risk

(2008) J. Brooks et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?

(2008) Anna Jakubowska et al.   EUROPEAN JOURNAL OF CANCER

Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients

(2008) Ewelina Synowiec et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS